UNSPSC 51332502: Azabuperone

This classification denotes an antipsychotic agent with the molecular formula C17H23FN2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 9P043590EX chemically known as 4'-fluoro-4-(hexahydropyrrolo(1,2-a)pyrazin-2(1h)-yl)butyrophenone but generally known as azabuperone, which bears US NIH Compound Identifier 18484. European Medicines Agency schedules Azabuperone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05623MIG.

UNSPSC 51332502 Azabuperone is a Commodity code that does not align with the recent state and local procurement activity tagged to it. The solicitation record names naloxone and safe drug deactivation systems as the products being procured, not azabuperone. This mismatch suggests either a data-entry error in the coding assignment or a fundamental misclassification of the opportunity within the taxonomy. The code shows little relevant recent activity under its nominal scope.

Seminole County, Florida posted IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with a response deadline of July 26, 2023. Quarterly deliveries are required to the Seminole County Community Health Building in Sanford, Florida, with vendors responsible for all shipping and delivery costs. The contract carries a two-year initial term with a one-year renewal option and includes a three-month probationary period allowing termination at will. Bidders must submit electronically, provide unit costs for each line item, maintain drug-free workplace certification and E-Verify compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The procurement is potentially FEMA-funded and subjects contractors to Clean Air Act and Federal Water Pollution Control Act compliance, audits, and record inspections.